
CAS 1001600-54-9
:Formel:C33H44N4O5
InChl:InChI=1S/C33H44N4O5/c1-22(34-2)30(38)35-28(25-18-11-6-12-19-25)32(40)37-21-13-20-26(37)31(39)36-29(33(41)42-3)27(23-14-7-4-8-15-23)24-16-9-5-10-17-24/h4-5,7-10,14-17,22,25-29,34H,6,11-13,18-21H2,1-3H3,(H,35,38)(H,36,39)/t22-,26-,28-,29-/m0/s1
InChI Key:UUPZYAHONNHULX-CJBSCAABSA-N
SMILES:C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)OC)NC
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
5 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
MV1
CAS:MV1 is an IAP antagonist. When combined with HaloTag ligand, MV1 causes protein knockdown of HaloTag-fused proteins.Formel:C33H44N4O5Reinheit:99.86%Farbe und Form:SolidMolekulargewicht:576.7263MV1
CAS:Methyl (S)-2-((S)-1-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamido)-3,3-diphenylpropanoateFormel:C33H44N4O5Reinheit:99%Molekulargewicht:576.73MV1
CAS:MV1 is a protein that belongs to the group of calcium binding proteins. It has been shown to be an important biomarker for active antiretroviral therapy in HIV-infected patients. MV1 is also expressed at high levels in primary cells, such as T lymphocytes and macrophages, and can be used as a marker for cell lysis in model organisms, such as mice. The protein has been shown to have potential therapeutic applications in the treatment of obesity-related disorders by regulating body mass index (BMI). MV1 has also been shown to bind bacterial strains and viruses, which makes it a potential diagnostic tool. This protein can also act as a vector for experimental models.Formel:C33H44N4O5Reinheit:Min. 95%Molekulargewicht:576.73 g/mol




